Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Progyny Inc (NASDAQ: PGNY) closed the day trading at $20.03 up 0.40% from the previous closing price of $19.95. In other words, the price has increased by $0.40 from its previous closing price. On the day, 1.94 million shares were traded. PGNY stock price reached its highest trading level at $20.19 during the session, while it also had its lowest trading level at $19.67.
Ratios:
For a better understanding of PGNY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.85. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 2.80. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On November 13, 2024, Truist Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $26 to $19.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 26 ’24 when Schlanger David J bought 150,000 shares for $14.68 per share. The transaction valued at 2,202,330 led to the insider holds 228,269 shares of the business.
Anevski Peter bought 209,500 shares of PGNY for $3,034,084 on Dec 23 ’24. The CHIEF EXECUTIVE OFFICER now owns 441,463 shares after completing the transaction at $14.48 per share. On Dec 09 ’24, another insider, SEIDENBERG BETH C, who serves as the Director of the company, bought 39,680 shares for $15.82 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGNY now has a Market Capitalization of 1710828416 and an Enterprise Value of 1502146048. As of this moment, Progyny’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.44, and their Forward P/E ratio for the next fiscal year is 23.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.47 while its Price-to-Book (P/B) ratio in mrq is 4.05. Its current Enterprise Value per Revenue stands at 1.287 whereas that against EBITDA is 21.268.
Stock Price History:
The Beta on a monthly basis for PGNY is 1.38, which has changed by -0.4341808 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, PGNY has reached a high of $38.98, while it has fallen to a 52-week low of $13.39. The 50-Day Moving Average of the stock is -5.85%, while the 200-Day Moving Average is calculated to be -5.06%.
Shares Statistics:
Over the past 3-months, PGNY traded about 1.96M shares per day on average, while over the past 10 days, PGNY traded about 2470580 shares per day. A total of 85.31M shares are outstanding, with a floating share count of 71.37M. Insiders hold about 16.44% of the company’s shares, while institutions hold 90.31% stake in the company. Shares short for PGNY as of 1740700800 were 11371537 with a Short Ratio of 5.82, compared to 1738281600 on 11470131. Therefore, it implies a Short% of Shares Outstanding of 11371537 and a Short% of Float of 16.870001000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
